Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.92M | 6,452,398 | 6.87% | 93.13% | Net Selling | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $19.04M | 51,456,077 | 9.94% | 11.78% | Net Buying | |||
| IMA | IMAGENEBIO INC | $33.06M | 4,021,508 | 75.44% | 24.56% | Net Buying | |||
| ACXP | ACURX PHARMACEUTICALS INC | $8.16M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| ATYR | ATYR PHARMA INC | $72.45M | 89,004,436 | 74.54% | 17.28% | Net Buying | Net Buying | ||
| MRSN | MERSANA THERAPEUTICS INC | $42.22M | 4,990,692 | 30.77% | 69.23% | Net Selling | Net Selling | ||
| CANF | CAN-FITE BIOPHARMA LTD | $4.95M | 3,967,407,393 | 0.02% | 0.00% | ||||
| NRXP | NRX PHARMACEUTICALS INC | $52.42M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| SGMO | SANGAMO THERAPEUTICS INC | $165.94M | 301,709,485 | 16.98% | 10.65% | Net Selling | Net Selling | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $27.08M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| PSTV | PLUS THERAPEUTICS INC | $74.90M | 137,429,055 | 0.28% | 17.25% | Net Buying | Net Buying | ||
| GRI | GRI BIO INC | $4.23M | 2,515,305 | 0.71% | 99.29% | ||||
| FGEN | FIBROGEN INC | $44.48M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Selling | ||
| TVRD | TVARDI THERAPEUTICS INC | $39.57M | 9,377,433 | 5.93% | 94.07% | Net Selling | |||
| CING | CINGULATE INC | $20.68M | 5,412,523 | 3.75% | 96.25% | ||||
| JSPR | JASPER THERAPEUTICS INC | $31.69M | 16,253,332 | 20.42% | 79.58% | Net Buying | Net Buying | ||
| MDCX | MEDICUS PHARMA LTD | $40.98M | 17,816,266 | 11.79% | 55.54% | Net Buying | Net Buying | ||
| LSTA | LISATA THERAPEUTICS INC | $20.12M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $23.86M | 23,858,301 | 10.74% | 60.23% | ||||
| SKYE | SKYE BIOSCIENCE INC | $46.79M | 30,988,420 | 2.80% | 97.20% | Net Selling | Net Selling | ||
| IMUX | IMMUNIC INC | $69.28M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| MYO | MYOMO INC | $32.62M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| PHIO | PHIO PHARMACEUTICALS CORP | $9.05M | 5,726,750 | 0.16% | 99.84% | Net Buying | Net Selling | ||
| PASG | PASSAGE BIO INC | $21.30M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Buying | ||
| ACET | ADICET BIO INC | $57.07M | 82,709,625 | 62.39% | 20.18% | Net Buying | Net Buying | ||
| PMN | PROMIS NEUROSCIENCES INC | $21.24M | 51,806,497 | 16.36% | 61.54% | Net Buying | Net Buying | ||
| MBRX | MOLECULIN BIOTECH INC | $14.45M | 30,286,168 | 1.43% | 20.90% | Net Buying | |||
| FEMY | FEMASYS INC | $22.75M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| VNRX | VOLITIONRX LTD | $46.37M | 107,595,421 | 22.29% | 35.39% | Net Buying | Net Buying | ||
| TIL | INSTIL BIO INC | $104.23M | 6,750,716 | 5.76% | 94.24% | Net Buying | Net Buying | ||
| MTVA | METAVIA INC | $24.20M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| CTSO | CYTOSORBENTS CORP | $46.64M | 62,610,376 | 26.26% | 45.19% | Net Buying | |||
| BMEA | BIOMEA FUSION INC | $79.74M | 59,508,518 | 48.27% | 28.91% | Net Buying | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.19M | 1,261,290 | 0.39% | 99.61% | Net Selling | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $9.35M | 1,919,441 | 4.25% | 95.75% | Net Buying | |||
| RNXT | RENOVORX INC | $37.75M | 36,645,884 | 24.00% | 11.42% | Net Buying | Net Buying | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $246.29M | 221,881,029 | 70.15% | 29.85% | Net Selling | Net Selling | ||
| ATOS | ATOSSA THERAPEUTICS INC | $106.95M | 129,171,424 | 16.53% | 11.04% | Net Buying | |||
| TCRX | TSCAN THERAPEUTICS INC | $64.41M | 56,747,993 | 62.95% | 29.87% | Net Buying | |||
| SLN | SILENCE THERAPEUTICS PLC | $294.45M | 141,701,848 | 13.95% | 0.09% | ||||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.77M | 2,623,233 | 0.26% | 99.74% | ||||
| ANVS | ANNOVIS BIO INC | $39.75M | 19,486,231 | 9.30% | 15.63% | Net Buying | Net Buying | ||
| FBRX | FORTE BIOSCIENCES INC | $128.06M | 12,432,854 | 61.45% | 38.55% | Net Buying | Net Selling | ||
| NEUP | NEUPHORIA THERAPEUTICS INC | $10.37M | 2,357,613 | 2.53% | 97.47% | Net Buying | Net Buying | ||
| HUMA | HUMACYTE INC | $229.64M | 158,372,173 | 35.97% | 19.03% | Net Selling | Net Selling | ||
| NAKA | KINDLY MD INC | $6.15M | 7,606,339 | 0.57% | 99.43% | Net Buying | |||
| NKTX | NKARTA INC | $138.50M | 71,024,512 | 62.30% | 37.70% | Net Selling | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $627.88M | 85,893,834 | 37.84% | 5.17% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.